Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP207459.RAV-kTTa0deDYAhNQcWJmn-lxZjUgp_cx_sDi3aPB4RwQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP207459.RAV-kTTa0deDYAhNQcWJmn-lxZjUgp_cx_sDi3aPB4RwQ130_assertion type Assertion NP207459.RAV-kTTa0deDYAhNQcWJmn-lxZjUgp_cx_sDi3aPB4RwQ130_head.
- NP207459.RAV-kTTa0deDYAhNQcWJmn-lxZjUgp_cx_sDi3aPB4RwQ130_assertion description "[PLA2 polymorphism was present in 44.2% of cases and 18.4% of controls, and cases with one (n = 24) event had an odds ratio (OR) = 2.7 (95% confidence interval [CI] 0.7-10.0), with two events (n = 52) an OR = 3.8 (95% CI 1.3-11.5), and with three (n = 16) or four abortions (n = 6) had a combined OR = 4.4 (95% CI 1.2-17.0), compared to controls, indicating that PLA2 polymorphism may be implicated in an inherited form of thrombophilia, and to early fetal loss.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP207459.RAV-kTTa0deDYAhNQcWJmn-lxZjUgp_cx_sDi3aPB4RwQ130_provenance.
- NP207459.RAV-kTTa0deDYAhNQcWJmn-lxZjUgp_cx_sDi3aPB4RwQ130_assertion evidence source_evidence_literature NP207459.RAV-kTTa0deDYAhNQcWJmn-lxZjUgp_cx_sDi3aPB4RwQ130_provenance.
- NP207459.RAV-kTTa0deDYAhNQcWJmn-lxZjUgp_cx_sDi3aPB4RwQ130_assertion SIO_000772 15705408 NP207459.RAV-kTTa0deDYAhNQcWJmn-lxZjUgp_cx_sDi3aPB4RwQ130_provenance.
- NP207459.RAV-kTTa0deDYAhNQcWJmn-lxZjUgp_cx_sDi3aPB4RwQ130_assertion wasDerivedFrom befree-20140225 NP207459.RAV-kTTa0deDYAhNQcWJmn-lxZjUgp_cx_sDi3aPB4RwQ130_provenance.
- NP207459.RAV-kTTa0deDYAhNQcWJmn-lxZjUgp_cx_sDi3aPB4RwQ130_assertion wasGeneratedBy ECO_0000203 NP207459.RAV-kTTa0deDYAhNQcWJmn-lxZjUgp_cx_sDi3aPB4RwQ130_provenance.